Calton & Associates Inc. Has $612,000 Holdings in The Procter & Gamble Company (NYSE:PG)

Calton & Associates Inc. grew its holdings in The Procter & Gamble Company (NYSE:PGFree Report) by 38.8% in the 3rd quarter, Holdings Channel reports. The fund owned 3,536 shares of the company’s stock after purchasing an additional 989 shares during the quarter. Calton & Associates Inc.’s holdings in Procter & Gamble were worth $612,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Legal & General Group Plc boosted its stake in Procter & Gamble by 0.6% in the 2nd quarter. Legal & General Group Plc now owns 21,632,054 shares of the company’s stock worth $3,567,556,000 after purchasing an additional 122,190 shares during the period. Dimensional Fund Advisors LP raised its stake in shares of Procter & Gamble by 8.2% in the 2nd quarter. Dimensional Fund Advisors LP now owns 9,691,925 shares of the company’s stock valued at $1,598,510,000 after purchasing an additional 733,440 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. lifted its holdings in shares of Procter & Gamble by 9.7% in the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 6,161,507 shares of the company’s stock valued at $999,705,000 after purchasing an additional 545,601 shares in the last quarter. Janus Henderson Group PLC boosted its position in shares of Procter & Gamble by 1.3% during the first quarter. Janus Henderson Group PLC now owns 6,008,938 shares of the company’s stock worth $974,914,000 after buying an additional 79,665 shares during the period. Finally, Canada Pension Plan Investment Board raised its position in Procter & Gamble by 3.9% in the 2nd quarter. Canada Pension Plan Investment Board now owns 5,706,199 shares of the company’s stock valued at $941,066,000 after buying an additional 216,300 shares during the last quarter. Institutional investors own 65.77% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the stock. BNP Paribas initiated coverage on shares of Procter & Gamble in a research note on Monday, June 24th. They set an “outperform” rating and a $187.00 price target for the company. Deutsche Bank Aktiengesellschaft lifted their target price on Procter & Gamble from $171.00 to $176.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th. Dbs Bank cut Procter & Gamble from a “strong-buy” rating to a “hold” rating in a research report on Thursday, August 1st. DZ Bank raised Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 price target for the company in a research report on Thursday, August 29th. Finally, Jefferies Financial Group cut Procter & Gamble from a “buy” rating to a “hold” rating and reduced their price target for the company from $182.00 to $175.00 in a research report on Wednesday, July 24th. Nine analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $177.00.

Check Out Our Latest Analysis on PG

Procter & Gamble Stock Down 0.1 %

Shares of PG traded down $0.18 during trading hours on Tuesday, reaching $169.36. The stock had a trading volume of 1,833,892 shares, compared to its average volume of 6,663,287. The Procter & Gamble Company has a 12 month low of $142.50 and a 12 month high of $177.94. The firm has a 50-day simple moving average of $171.82 and a 200 day simple moving average of $167.33. The company has a current ratio of 0.73, a quick ratio of 0.53 and a debt-to-equity ratio of 0.51. The company has a market capitalization of $399.71 billion, a price-to-earnings ratio of 27.71, a P/E/G ratio of 3.74 and a beta of 0.41.

Procter & Gamble (NYSE:PGGet Free Report) last released its quarterly earnings results on Friday, October 18th. The company reported $1.93 EPS for the quarter, beating analysts’ consensus estimates of $1.90 by $0.03. The business had revenue of $21.74 billion during the quarter, compared to analyst estimates of $21.99 billion. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. Procter & Gamble’s quarterly revenue was down .6% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.83 EPS. Equities research analysts predict that The Procter & Gamble Company will post 6.97 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be given a dividend of $1.0065 per share. This represents a $4.03 annualized dividend and a dividend yield of 2.38%. The ex-dividend date is Friday, October 18th. Procter & Gamble’s dividend payout ratio is presently 65.69%.

Insider Activity

In related news, insider Balaji Purushothaman sold 8,842 shares of Procter & Gamble stock in a transaction dated Thursday, August 1st. The stock was sold at an average price of $164.90, for a total value of $1,458,045.80. Following the completion of the sale, the insider now owns 11,537 shares of the company’s stock, valued at approximately $1,902,451.30. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other Procter & Gamble news, insider Balaji Purushothaman sold 8,842 shares of the firm’s stock in a transaction dated Thursday, August 1st. The stock was sold at an average price of $164.90, for a total value of $1,458,045.80. Following the completion of the transaction, the insider now owns 11,537 shares in the company, valued at $1,902,451.30. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Andre Schulten sold 13,041 shares of the firm’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $170.00, for a total value of $2,216,970.00. Following the completion of the transaction, the chief financial officer now owns 37,208 shares of the company’s stock, valued at approximately $6,325,360. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 383,194 shares of company stock valued at $65,140,718 in the last ninety days. 0.17% of the stock is currently owned by insiders.

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Featured Articles

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.